A non-invasive diabetes detection device designed for clinical diagnostic use without requiring invasive procedures.
Manufactured by
Shenzhen Create Medical Technology Co., Ltd.
China
Shenzhen Create Medical Technology Co., Ltd. manufactures breath diagnostic devices for detecting conditions including H. pylori infection (13C/14C breath tests), gastrointestinal disorders (hydrogen/methane analyzers), airway inflammation (NO analyzers), and halitosis (VSC analyzers). The company also produces non-invasive diabetes screening equipment using AGE detection technology and AI-assisted medical examination systems. Products are exported to over 20 countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KANROTA
China · 2 relevant products
Anhui Huibang Biological Engineering Co., Ltd.
China · 3 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
45 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 62 closest product alternatives
KANROTA · China
Non-invasive skin autofluorescence measurement system for advanced glycation end products assessment. Enables early diabetes detection and complication risk stratification. Optical measurement technology without sample collection.
Anhui Huibang Biological Engineering Co., Ltd. · China
An in vitro detection system for early diagnosis indicators of diabetic nephropathy in human urine. It features multi-channel composite detection with selected indicator combinations including urinary microalbumin, urinary haptoglobin, and urinary creatinine as an internal standard. The system uses dry biochemistry and immunology methods, allows random urine self-testing without invasive procedures, and supports home-based testing with mobile device image upload for server analysis and professional feedback.
Anhui Huibang Biological Engineering Co., Ltd. · China
An invention patent product (ZL 2017 1 0507989.9) for in vitro detection of early diagnostic markers of diabetic kidney disease in human urine. It is a Class II urine detection product using dry biochemistry and immunology methods with multi-channel composite detection. The system detects urine microalbumin, urine haptoglobin, and urine creatinine as internal standard. It features non-invasive random urine self-testing, stable dry reagents, and can be used for home self-testing with mobile device result upload for server-based analysis and professional feedback.
59 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products